Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Discover the best timing for robo versus manual investing in 2026. This intro outlines criteria, costs, and expected outcomes to guide your choice.
26,911 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
SanDisk moved down about 5% after reporting strong Q4 results, fueling a sharp debate on whether the AI-led rally in ...
Delinquencies eased in March to 3.35%, though higher-severity stress remains elevated. FHA loans push delinquency sha...
Analysts debate Cardano's valuation as ADA weakens and on-chain metrics lag, challenging bulls and funds alike. The d...
XRP slid about 19% over the past week, hitting multi-month lows. A ChatGPT-style AI forecast points to a potential ne...
A new income strategy is gaining traction among retirees and advisers: a retirement portfolio that forks into dual in...
A new LodeStar study shows national purchase loan closing costs declined 2.9% in 2025, driven by lower home prices an...
A late-July meeting to craft an ethics clause for the President’s crypto holdings stalled, keeping Clarity Act negoti...
Two heavyweight banks reported solid Q4 2025 results, but investors remain focused on dividends, buybacks and how eac...
Baidu shares slumped after a hefty impairment charge underscored the heavy costs of its AI push, even as AI Cloud rev...
As Commvault shares dive, a fresh $19.8 million stake signals confidence from a hedge fund with a plan. Here's how to...
The United States faces a thinner fiscal buffer as debt climbs to $39 trillion, now taller than annual GDP. A top eco...